Niki Karavitaki on the risk of brain tumours after radiotherapy for pituitary adenoma
Niki Karavitaki talks with The Lancet Diabetes & Endocrinology about the risk of a second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma. Read the full article: Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma
Continue this conversation on social! Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
The Lancet Diabetes & Endocrinology in conversation with... is part of the Lancet Group podcast offering.
Editorial team: Marta Koch, David Holmes, and Susan Rahimi
Podcast editing and production: Matteo Simonetti
Visit https://www.thelancet.com/multimedia to learn more about our multimedia offering.
Find the best science for better lives at https://www.thelancet.com/journals/landia/home Follow us today at... https://thelancet.bsky.social/ https://instagram.com/thelancetgroup https://facebook.com/thelancetmedicaljournal https://linkedIn.com/company/the-lancet https://youtube.com/thelancettv
Otros episodios de "The Lancet Diabetes & Endocrinology in conversation with"
No te pierdas ningún episodio de “The Lancet Diabetes & Endocrinology in conversation with”. Síguelo en la aplicación gratuita de GetPodcast.
